REED ELIZABETH E

CIK 00012833033 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001283303

Recent Transactions

26 trades

Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-02-01$22.25/sh−2,590→ 57,436 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-02-01$22.25/sh−2,590→ 57,436 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2023-01-31+6,750→ 6,750 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2023-01-31+54,500→ 54,500 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-31+20,250→ 60,026 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2023-01-31+54,500→ 54,500 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2023-01-31+6,750→ 6,750 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-31+20,250→ 60,026 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-24$21.50/sh−2,062→ 39,776 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-24$21.50/sh−2,062→ 39,776 total
Award
Eiger BioPharmaceuticals, Inc.
Stock option (right to buy)
2015-01-01+72,000→ 142,500 total
Award
Eiger BioPharmaceuticals, Inc.
Stock option (right to buy)
2015-01-01+72,000→ 142,500 total
Award
ANADYS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2011-01-20+50,000→ 50,000 total
Award
ANADYS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2011-01-20+50,000→ 50,000 total
Award
ANADYS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2006-12-08+45,000→ 45,000 total
Award
ANADYS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2006-12-08+45,000→ 45,000 total
Exercise/Conversion
ANADYS PHARMACEUTICALS INC
Stock Option (Right To Buy)
2006-01-09−1,500→ 10,265 total
Sale
ANADYS PHARMACEUTICALS INC
Common Stock
2006-01-09$10.02/sh−100→ 0 total
Sale
ANADYS PHARMACEUTICALS INC
Common Stock
2006-01-09$10.01/sh−200→ 200 total
Sale
ANADYS PHARMACEUTICALS INC
Common Stock
2006-01-09$10.00/sh−1,200→ 300 total
Exercise/Conversion
ANADYS PHARMACEUTICALS INC
Stock Option (Right To Buy)
2006-01-09−1,500→ 10,265 total
Sale
ANADYS PHARMACEUTICALS INC
Common Stock
2006-01-09$10.00/sh−1,200→ 300 total
Exercise/Conversion
ANADYS PHARMACEUTICALS INC
Common Stock
2006-01-09$2.95/sh+1,500→ 1,500 total
Sale
ANADYS PHARMACEUTICALS INC
Common Stock
2006-01-09$10.01/sh−200→ 200 total
Sale
ANADYS PHARMACEUTICALS INC
Common Stock
2006-01-09$10.02/sh−100→ 0 total
Exercise/Conversion
ANADYS PHARMACEUTICALS INC
Common Stock
2006-01-09$2.95/sh+1,500→ 1,500 total

Companies

Recent Filings

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov